Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « AbsEn.i » - entrée « reported »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
report < reported < reportedly  Facettes :

List of bibliographic references indexed by reported

Number of relevant bibliographic references: 191.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
000299 (2021) Marko Boban [Croatie]Novel coronavirus disease (COVID-19) update on epidemiology, pathogenicity, clinical course and treatments.
000339 (2021) Ritwick Mondal [Inde] ; Upasana Ganguly [Inde] ; Shramana Deb [Inde] ; Gourav Shome [Inde] ; Subhasish Pramanik [Inde] ; Deebya Bandyopadhyay [Inde] ; Durjoy Lahiri [Inde]Meningoencephalitis associated with COVID-19: a systematic review.
000341 (2021) Kaho Shionoya [Japon] ; Masako Yamasaki [Japon] ; Shoya Iwanami [Japon] ; Yusuke Ito [Japon] ; Shuetsu Fukushi [Japon] ; Hirofumi Ohashi [Japon] ; Wakana Saso [Japon] ; Tomohiro Tanaka [Japon] ; Shin Aoki [Japon] ; Kouji Kuramochi [Japon] ; Shingo Iwami [Japon] ; Yoshimasa Takahashi [Japon] ; Tadaki Suzuki [Japon] ; Masamichi Muramatsu [Japon] ; Makoto Takeda [Japon] ; Takaji Wakita [Japon] ; Koichi Watashi [Japon]Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro.
000366 (2021) Emmaline Zantua Fernando [Philippines] ; Jeryl Ritzi Tan Yu [Philippines] ; Salvador Miclat Abad Santos [Philippines] ; Roland Dominic Go Jamora [Philippines]Involuntary Movements Following Administration of Hydroxychloroquine for COVID-19 Pneumonia.
000367 (2021) Hernando Trujillo [Espagne] ; Mario Fernández-Ruiz [Espagne] ; Eduardo Gutiérrez [Espagne] ; Ángel Sevillano [Espagne] ; Fernando Caravaca-Fontán [Espagne] ; Enrique Morales [Espagne] ; Francisco L Pez-Medrano [Espagne] ; José María Aguado [Espagne] ; Manuel Praga [Espagne] ; Amado Andrés [Espagne]Invasive pulmonary aspergillosis associated with COVID-19 in a kidney transplant recipient.
000372 (2021) Jyoti Choudhary [Inde] ; Shrivardhan Dheeman [Inde] ; Vipin Sharma [Inde] ; Prashant Katiyar [Inde] ; Santosh Kumar Karn [Inde] ; Manoj Kumar Sarangi [Inde] ; Ankit Kumar Chauhan [Inde] ; Gaurav Verma [Inde] ; Nitin Baliyan [Inde]Insights of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) pandemic: a current review.
000375 (2021) Mustafa M. Kadhim [Iraq] ; Abbas Washeel Salman [Iraq] ; Ameerah Mrebee Zarzoor [Iraq] ; Wesam R. Kadhum [Iraq]Inhibition of SARS-CoV-2 reproduction using Boswellia carterii: A theoretical study.
000391 (2021) Yufeng Shang [République populaire de Chine] ; Tao Liu [République populaire de Chine] ; Jingfeng Li [République populaire de Chine] ; Natasha Mupeta Kaweme [République populaire de Chine] ; Xinghuan Wang [République populaire de Chine] ; Fuling Zhou [République populaire de Chine]Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus.
000392 (2021) Esam Abualfadl [Égypte] ; Faten Ismail [Égypte] ; Rawhya R El Shereef [Égypte] ; Eman Hassan [Égypte] ; Samar Tharwat [Égypte] ; Eman F. Mohamed [Égypte] ; Essam A. Abda [Égypte] ; Ahmed R. Radwan [Égypte] ; Rasha M. Fawzy [Égypte] ; Abdel Hafeez Moshrif [Égypte] ; Rasha Abdel Noor [Égypte] ; Soha Senara [Égypte] ; Mervat I Abd Elazim [Égypte] ; Nouran M. Abaza [Égypte] ; Hala A. Raafat [Égypte] ; Iman I. El-Gazzar [Égypte] ; Dina H. El-Hammady [Égypte] ; Nevin Hammam [Égypte, États-Unis] ; Tamer A. Gheita [Égypte] ; Reem El-Mallah [Égypte]Impact of COVID-19 pandemic on rheumatoid arthritis from a Multi-Centre patient-reported questionnaire survey: influence of gender, rural-urban gap and north-south gradient.
000398 (2021) Pankaj Bansal [États-Unis] ; Amandeep Goyal [États-Unis] ; Austin Cusick [États-Unis] ; Shubham Lahan [Inde] ; Harpal S. Dhaliwal [Inde] ; Poonam Bhyan [États-Unis] ; Pradnya Brijmohan Bhattad [États-Unis] ; Fawad Aslam [États-Unis] ; Sagar Ranka [États-Unis] ; Tarun Dalia [États-Unis] ; Lovely Chhabra [États-Unis] ; Devang Sanghavi [États-Unis] ; Bhavin Sonani [États-Unis] ; John M. Davis [États-Unis]Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019.
000428 (2021) A A Kamalov [Russie] ; V Yu Mareev [Russie] ; Ya A. Orlova [Russie] ; A G Plisyk [Russie] ; Z A Akopyan [Russie] ; Yu V. Mareev [Royaume-Uni] ; E A Mershina [Russie] ; Yu L. Begrambekova [Russie] ; P V Pakhomov [Russie]Hydroxychloroquine in patients with novel coronavirus infection (COVID-19): a case-control study.
000437 (2021) Hozaifa Khalil Elsawah [Égypte] ; Mohamed Ahmed Elsokary [Égypte] ; Mahmoud Gamal Elrazzaz [Égypte] ; Ahmed Hanei Elshafie [Égypte]Hydroxychloroquine for treatment of nonsevere COVID-19 patients: Systematic review and meta-analysis of controlled clinical trials.
000454 (2021) Hang Xu [République populaire de Chine] ; Xiang Yang Zhang [République populaire de Chine] ; Wei Wen Wang [République populaire de Chine] ; Jiesi Wang [République populaire de Chine]Hydroxychloroquine Increased Anxiety-Like Behaviors and Disrupted the Expression of Some Related Genes in the Mouse Brain.
000466 (2021) Iram Iqbal Hejazi [Inde] ; Md Amjad Beg [Inde] ; Md Ali Imam [Inde] ; Fareeda Athar [Inde] ; Asimul Islam [Inde]Glossary of phytoconstituents: Can these be repurposed against SARS CoV-2? A quick in silico screening of various phytoconstituents from plant Glycyrrhiza glabra with SARS CoV-2 main protease.
000478 (2021) Hardeep Kaur [Inde] ; Phulen Sarma [Inde] ; Anusuya Bhattacharyya [Inde] ; Manisha Prajapat [Inde] ; Subodh Kumar [Inde] ; Ajay Prakash [Inde] ; Bikash Medhi [Inde]Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable?
000491 (2021) Gaurav Joshi [Inde] ; Shikha Thakur [Inde] ; Mayank [Inde] ; Ramarao Poduri [Inde]Exploring insights of hydroxychloroquine, a controversial drug in Covid-19: An update.
000555 (2021) Milo Gatti [Italie] ; Fabrizio De Ponti [Italie]Drug Repurposing in the COVID-19 Era: Insights from Case Studies Showing Pharmaceutical Peculiarities.
000556 (2021) Biswa Mohan Sahoo [Inde] ; B V V. Ravi Kumar [Inde] ; J. Sruti [Inde] ; Manoj Kumar Mahapatra [Inde] ; Bimal K. Banik [Arabie saoudite] ; Preetismita Borah [Inde]Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection.
000562 (2021) Jia-Bao Liu ; Micheal Arockiaraj ; M. Arulperumjothi ; Savari PrabhuDistance based and bond additive topological indices of certain repurposed antiviral drug compounds tested for treating COVID-19.
000566 (2021) Xisheng Xiong [République populaire de Chine] ; Kun Wang [République populaire de Chine] ; Tao Tang [République populaire de Chine] ; Jinzhi Fang [République populaire de Chine] ; Yijun Chen [République populaire de Chine]Development of a chiral HPLC method for the separation and quantification of hydroxychloroquine enantiomers.
000585 (2021) Ruby Gupta [États-Unis] ; Sukhmani Singh [États-Unis] ; Nwabundo Anusim [États-Unis] ; Sachin Gupta [États-Unis] ; Sorab Gupta [États-Unis] ; Marianne Huben [États-Unis] ; George Howard [États-Unis] ; Ishmael Jaiyesimi [États-Unis]Coronavirus Disease 2019 and Cold Agglutinin Syndrome: An Interesting Case.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "reported" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i  \
                -Sk "reported" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    reported
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021